Evidence map›Paper›PMID 37428408›Full record

ReviewCerebellum (London, England)2024

Consensus Paper: Cerebellum and Ageing.

Angelo Arleo, Martin Bareš, Jessica A Bernard, Hannah R Bogoian, Muriel M K Bruchhage, Patrick Bryant, Erik S Carlson, Chetwyn C H Chan, Liang-Kung Chen, Chih-Ping Chung and 19 more

Registry-linked trialOpen access · greenAbstract readReviewConsensus Statement
In one paragraph

Review in Cerebellum (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06669182 (Effects of Cerebellar Transcranial Magnetic Stimulation on Patients With Alzheimer's Disease:A Multicenter Randomized Controlled Trial), which is not on this map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06669182 narecruitingnot on this mapstarted 2025, after this paper: background citation

Effects of Cerebellar Transcranial Magnetic Stimulation on Patients With Alzheimer's Disease:A Multicenter Randomized Controlled Trial

TypeinterventionalSponsorXijing HospitalRan2025 to 2026Enrolled100ConditionsAlzheimer Disease, Transcranial Magnetic Stimulation, CerebellumArmsIntermittent Theta-Burst Transcranial Magnetic Stimulation
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Depression and anxiety in vascular dementia: an update.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 11 countries.

Angelo ArleoSorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.
Martin BarešFirst Department of Neurology, Faculty of Medicine, Masaryk University and St. Anne's Teaching Hospital, Brno, Czech Republic.
Jessica A BernardDepartment of Psychological and Brain Sciences, Texas A&M University, 4235 TAMU, College Station, TX, 77843, USA.
Hannah R BogoianDepartment of Psychology, Georgia State University, Atlanta, GA, USA.
Muriel M K BruchhageDepartment of Psychology, Stavanger University, Institute of Social Sciences, Kjell Arholms Gate 41, 4021, Stavanger, Norway.
Patrick BryantFreie Universität Berlin, Fachbereich Mathematik und Informatik, Arnimallee 12, 14195, Berlin, Germany.
Erik S CarlsonDepartment of Psychiatry and Behavioural Sciences, University of Washington, Seattle, WA, USA.
Chetwyn C H ChanDepartment of Psychology, The Education University of Hong Kong, New Territories, Tai Po, Hong Kong, China.
Liang-Kung ChenCenter for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan.
Chih-Ping ChungCenter for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan.
Vonetta M DotsonDepartment of Psychology, Georgia State University, Atlanta, GA, USA.
Pavel FilipDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
Xavier GuellDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Christophe HabasCHNO Des Quinze-Vingts, INSERM-DGOS CIC 1423, 28 rue de Charenton, 75012, Paris, France.
Heidi I L JacobsSchool for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, PO BOX 616, 6200, MD, Maastricht, The Netherlands.
Shinji KakeiJissen Women's University, Tokyo, Japan.
Tatia M C LeeState Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong, China.
Maria LeggioDepartment of Psychology, Sapienza University of Rome, Rome, Italy.
Maria MisiuraDepartment of Psychology, Georgia State University, Atlanta, GA, USA.
Hiroshi MitomaDepartment of Medical Education, Tokyo Medical University, Tokyo, Japan.
Giusy OlivitoDepartment of Psychology, Sapienza University of Rome, Rome, Italy.
Stephen RamanoëlSorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.
Zeynab RezaeeNoninvasive Neuromodulation Unit, Experimental Therapeutics & Pathophysiology Branch, National Institute of Mental Health, NIH, Bethesda, USA.
Colby L SamstagDepartment of Psychiatry and Behavioural Sciences, University of Washington, Seattle, WA, USA.
Jeremy D SchmahmannDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Kaoru SekiyamaGraduate School of Advanced Integrated Studies in Human Survivability, Kyoto University, Kyoto, Japan.
Clive H Y WongDepartment of Psychology, The Education University of Hong Kong, New Territories, Tai Po, Hong Kong, China.
Masatoshi YamashitaResearch Center for Child Mental Development, University of Fukui, Fukui, Japan.
Mario MantoService de Neurologie, Médiathèque Jean Jacquy, CHU-Charleroi, Charleroi, Belgium. mario.manto@ulb.be.
Georgia State University · USHarvard University · USEducation University of Hong Kong · HKFondazione Santa Lucia · ITInstitut de la Vision · FRUniversity of Minnesota · USUniversity of Washington · USBrown University · USCentre hospitalier national d'ophtalmologie des Quinze-Vingts · FRChiba University · JPFreie Universität Berlin · DEGrand Charleroi Hospital · BEJissen Women's University · JPKyoto University · JPNational Institute of Mental Health · USNational Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TWTexas A&M University · USTokyo Medical University · JPUniversity of Hong Kong · HK

Funding

Regulatory and Human Study Operations (RHSO) Core CU19AG065169 · NIA · UNIVERSITY OF ARIZONA · PI RYAN, LEE · 2021 to 2025
$59.8M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Amanda D. Boyd · 2020 to 2026
$29.0M
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)U19AG073172 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ANDERSEN, STACY, BOOKHEIMER, SUSAN Y · 2021 to 2025
$23.1M
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
UCLA Center for Translational Research in Neurodevelopment: UC-TRaNU54HD087101 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BOOKHEIMER, SUSAN Y · 2016 to 2020
$6.5M
A longitudinal investigation of the cerebellum in adulthood: anatomical and network changes, motor function, and cognitionR01AG064010 · NIA · TEXAS A&M UNIVERSITY · PI BERNARD, JESSICA ANN · 2019 to 2023
$3.1M
Motor learning of fall resistant skills from laboratory-induced falling among people with Alzheimer's diseaseR21AG077307 · NIA · GEORGIA STATE UNIVERSITY · PI YANG, FENG · 2022 to 2023
$429k
NIA NIH HHS P30 AG066509NIA NIH HHS R01 AG064010NIA NIH HHS R21 AG077307NIA NIH HHS T32 AG052354NIA NIH HHS U19 AG065169NIA NIH HHS U19 AG073172NICHD NIH HHS U54 HD087101
6 · The paper itself

Abstract

Given the key roles of the cerebellum in motor, cognitive, and affective operations and given the decline of brain functions with aging, cerebellar circuitry is attracting the attention of the scientific community. The cerebellum plays a key role in timing aspects of both motor and cognitive operations, including for complex tasks such as spatial navigation. Anatomically, the cerebellum is connected with the basal ganglia via disynaptic loops, and it receives inputs from nearly every region in the cerebral cortex. The current leading hypothesis is that the cerebellum builds internal models and facilitates automatic behaviors through multiple interactions with the cerebral cortex, basal ganglia and spinal cord. The cerebellum undergoes structural and functional changes with aging, being involved in mobility frailty and related cognitive impairment as observed in the physio-cognitive decline syndrome (PCDS) affecting older, functionally-preserved adults who show slowness and/or weakness. Reductions in cerebellar volume accompany aging and are at least correlated with cognitive decline. There is a strongly negative correlation between cerebellar volume and age in cross-sectional studies, often mirrored by a reduced performance in motor tasks. Still, predictive motor timing scores remain stable over various age groups despite marked cerebellar atrophy. The cerebello-frontal network could play a significant role in processing speed and impaired cerebellar function due to aging might be compensated by increasing frontal activity to optimize processing speed in the elderly. For cognitive operations, decreased functional connectivity of the default mode network (DMN) is correlated with lower performances. Neuroimaging studies highlight that the cerebellum might be involved in the cognitive decline occurring in Alzheimer's disease (AD), independently of contributions of the cerebral cortex. Grey matter volume loss in AD is distinct from that seen in normal aging, occurring initially in cerebellar posterior lobe regions, and is associated with neuronal, synaptic and beta-amyloid neuropathology. Regarding depression, structural imaging studies have identified a relationship between depressive symptoms and cerebellar gray matter volume. In particular, major depressive disorder (MDD) and higher depressive symptom burden are associated with smaller gray matter volumes in the total cerebellum as well as the posterior cerebellum, vermis, and posterior Crus I. From the genetic/epigenetic standpoint, prominent DNA methylation changes in the cerebellum with aging are both in the form of hypo- and hyper-methylation, and the presumably increased/decreased expression of certain genes might impact on motor coordination. Training influences motor skills and lifelong practice might contribute to structural maintenance of the cerebellum in old age, reducing loss of grey matter volume and therefore contributing to the maintenance of cerebellar reserve. Non-invasive cerebellar stimulation techniques are increasingly being applied to enhance cerebellar functions related to motor, cognitive, and affective operations. They might enhance cerebellar reserve in the elderly. In conclusion, macroscopic and microscopic changes occur in the cerebellum during the lifespan, with changes in structural and functional connectivity with both the cerebral cortex and basal ganglia. With the aging of the population and the impact of aging on quality of life, the panel of experts considers that there is a huge need to clarify how the effects of aging on the cerebellar circuitry modify specific motor, cognitive, and affective operations both in normal subjects and in brain disorders such as AD or MDD, with the goal of preventing symptoms or improving the motor, cognitive, and affective symptoms.

Indexed as

Major Depressive DisorderAdultAgedAgingCerebellumCross-Sectional StudiesHumansMagnetic Resonance ImagingQuality of LifeAffectiveAgingAlzheimer’s DiseaseCerebellumCognitiveMotor

Identifiers

PMID37428408
PMCPMC10776824
OpenAlexW4383710296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.